Estradiol and Levonorgestrel
- Product NDC
- 70710-2169
- Requested package NDC
- 70710-2169-8
- 11-digit product format
- 707102169
- Labeler code
- 70710
- Product ID
- 70710-2169_ff28c70c-0323-43b0-83d7-1a2635a10193
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Estradiol and Levonorgestrel
- Dosage form
- PATCH
- Route
- TRANSDERMAL
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA220407
- Marketing category
- ANDA
- Marketing start
- 2026-11-10
- Substance
- ESTRADIOL; LEVONORGESTREL
- Active strength
- .045; .015 mg/d; mg/d
- Pharmacologic classes
- Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine System [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220407-001 | ESTRADIOL AND LEVONORGESTREL | ESTRADIOL; LEVONORGESTREL | 0.045MG/24HR;0.015MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2026-10-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220407-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A220407-001 | ESTRADIOL AND LEVONORGESTREL | 0.045MG/24HR;0.015MG/24HR | FILM, EXTENDED RELEASE / TRANSDERMAL | AB | 2026-10-19 | d4dbc9d85df4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A220407-001 | AB | 1 | d4dbc9d85df4… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Estradiol and Levonorgestrel
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ESTRADIOL | .045 mg/d |
| LEVONORGESTREL | .015 mg/d |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4TI98Z838E | Internal UNII lookup |
| 5W7SIA7YZW | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| b143ebda-f5d7-4288-9a00-ba10a64f481f | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Estradiol and Levonorgestrel | ESTRADIOL AND LEVONORGESTREL | Zydus Pharmaceuticals USA Inc. | b143ebda-f5d7-4288-9a00-ba10a64f481f | 2026-11-03 | Boxed warning, Warnings, Adverse reactions | 220407 ANDA220407 70710-2169-8 70710-2169 70710216908 |
| Estradiol and Levonorgestrel | ESTRADIOL AND LEVONORGESTREL | Zydus Lifesciences Limited | 3fb00f13-d8b3-4391-9548-6ee912b2b5aa | 2026-11-02 | 220407 ANDA220407 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 70710-2169-8 | 70710216908 | 4 PATCH in 1 CARTON (70710-2169-8) / 7 d in 1 PATCH (70710-2169-1) | 4 patch | 2026-11-10 | No | No | Current |